The recruitment rate was estimated by the median density of TAMs measured in tumor nests from patients with basal-like breast cancer, a subtype similar to TNBC, by immunohistochemistry using a pan-macrophage marker, CD68 (Yang et al., 2018). The gene discussed is CD68; the disease is breast cancer.